References
- Beuers U, Boberg KM, Chapman RW, et al. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. J Hepatol. 2009;51:237–267.
- Chapman MH, Thorburn D, Hirschfield GM, et al. British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis. Gut. 2019;68:1356–1378.
- Beuers U, Kremer AE, Bolier R, et al. Pruritus in cholestasis: facts and fiction. Hepatology. 2014;60:399–407.
- Worwood M, Taylor DM, Hunt AH. Copper and manganese concentrations in biliary cirrhosis of liver. Br Med J. 1968;3:344–346.
- Dusek P, Litwin T, Czlonkowska A. Wilson disease and other neurodegenerations with metal accumulations. Neurol Clin. 2015;33:175–204.
- Zheng W, Fu SX, Dydak U, et al. Biomarkers of Manganese Intoxication. Neurotoxicology. 2011;32:1–8.
- Spahr L, Butterworth RF, Fontaine S, et al. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology. 1996;24:1116–1120.
- McMillan NB, Mulroy C, MacKay MW, et al. Correlation of cholestasis with serum copper and whole-blood manganese levels in pediatric patients. Nutr Clin Pract. 2008;23:161–165.
- Taba P. Metals and movement disorders. Curr Opin Neurol. 2013;26:435–441.
- Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet. 1995;346:270–274.
- Long L, Li X, Huang Z, et al. Relationship between changes in brain MRI and 1H-MRS, severity of chronic liver damage, and recovery after liver transplantation. Exp Biol Med (Maywood)). 2009;234:1075–1085.
- Layrargues GP, Rose C, Spahr L, et al. Role of manganese in the pathogenesis of portal-systemic encephalopathy. Metab Brain Dis. 1998;13:311–317.
- Shin HW, Park HK. Recent updates on acquired hepatocerebral degeneration. Tremor Other Hyperkinet Mov (N Y). 2017;7:463.
- Johnson MA, Fischer JG, Kays SE. Is copper an antioxidant nutrient? Crit Rev Food Sci Nutr. 1992;32:1–32.
- Coassin M, Ursini F, Bindoli A. Antioxidant effect of manganese. Arch Biochem Biophys. 1992;299:330–333.
- Anagianni S, Tuschl K. Genetic disorders of manganese metabolism. Curr Neurol Neurosci Rep. 2019;19:33.
- Lorincz MT. Neurologic Wilson’s disease. Ann N Y Acad Sci. 2010; 1184:173–187.
- Dastych M, Dastych M Jr, Senkyrik M. Manganese in whole blood and hair in patients with long-term home parenteral nutrition. Clin Lab. 2016;62:173–177.
- Cornelis R, Heinzow B, Herber RFM, et al. Sample collection guidelines for trace elements in blood and urine. J Trace Elements Med Biol. 1996;10:103–126.
- Sodi R, Taylor A. Vitamins and trace elements. In Rifai N, Horvath AR, Wittwer CT, editors. Tietz fundamentals of clinical chemistry and molecular diagnostics. 8th ed. St. Louis (MO): Elsevier; 2019. p. 495.
- Finley JW, Davis CD. Manganese deficiency and toxicity: are high or low dietary amounts of manganese cause for concern? Biofactors. 1999;10:15–24.
- Milkiewicz P, Heathcote EJ. Fatigue in chronic cholestasis. Gut. 2004;53:475–477.
- Forton DM, Patel N, Oatridge A, et al. Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut. 2004;53:587–592.
- O'Neal SL, Zheng W. Manganese toxicity upon overexposure: a decade in review. Curr Environ Health Rep. 2015;2:315–328.
- Cowan DM, Fan O, Zou Y, et al. Manganese exposure among smelting workers: blood manganese-iron ratio as a novel tool for manganese exposure assessment. Biomarkers. 2009;14:3–16.
- Wardle CA, Forbes A, Roberts NB, et al. Hypermanganesemia in long-term intravenous nutrition and chronic liver disease. JPEN J Parenter Enteral Nutr. 1999;23:350–355.
- Klos KJ, Ahlskog JE, Josephs KA, et al. Neurologic spectrum of chronic liver failure and basal ganglia T1 hyperintensity on magnetic resonance imaging: probable manganese neurotoxicity. Arch Neurol. 2005;62:1385–1390.